• Home
  • News

Zoetis Reintroduces Zoamix® To Help U.S. Poultry Producers Battle Coccidiosis

Versatile product can be used in antibiotic-free or conventional production systems

Monday, November 24, 2014 3:00 pm EST


Durham, N.C.
"Having one more anticoccidial to use in a rotation program — especially one like Zoamix, which has a unique chemical structure — could help preserve the efficacy of other coccidiosis medications"

DURHAM, N.C. - November 24, 2014 – Zoetis Inc. today announced the reintroduction of Zoamix® (zoalene), a versatile synthetic anticoccidial for the prevention and control of coccidiosis in broilers and turkeys.

“The U.S. poultry industry loses an estimated $600 million a year to coccidiosis[i], so the return of Zoamix could not be coming at a better time,” said Don Waldrip, DVM, DACPV, a senior technical services veterinarian with Zoetis.

He noted that U.S. poultry producers have not seen a new in-feed anticoccidial in 15 years[ii], and concerns remain about existing products becoming less effective over time. “Having one more anticoccidial to use in a rotation program — especially one like Zoamix, which has a unique chemical structure — could help preserve the efficacy of other coccidiosis medications,” Waldrip said.

Versatile Product

Zoamix is a Type A Medicated Article that can be used safely year-round with no withdrawal. Because it is a synthetic compound, Zoamix is compatible with antibiotic-free or conventional production systems. As with all in-feed anticoccidials, Zoetis recommends resting the medication periodically to maintain good efficacy. 

According to Waldrip, Zoamix is unique in that it’s a synthetic compound but works similarly to an ionophore by allowing some cycling of Eimeria, the parasite that causes coccidiosis. “That cycling, commonly called leakage by poultry producers and veterinarians, allows the development of natural immunity against the disease,” the veterinarian explained.

Waldrip said the arrival of Zoamix would further strengthen Rotecc Coccidiosis Management, a science-based initiative Zoetis launched earlier this year to help poultry producers develop more strategic, cost-effective and sustainable programs for battling the costly parasitic disease.

More Uses

In addition to preventing and controlling coccidiosis in broilers and turkeys, Zoamix can be used for the development of active immunity against coccidiosis in replacement chickens.  Zoamix is also approved for use in combination with BMD® (bacitracin methylene disalicylate), a feed medication used to manage necrotic enteritis in chickens and transmissible enteritis in turkeys.

Formerly produced by Alpharma, Zoamix was used by the U.S. broiler and turkey industries for more than four decades before leaving the market in 2005 due to shortage of a key ingredient.  Zoetis later acquired the product, saw the poultry industry’s need for Zoamix, and worked with suppliers to resolve supply issues and relaunch the product.

For more information about Zoamix and Rotecc Coccidiosis Management, poultry veterinarians, nutritionists and produces should contact their Zoetis representative or visit www.ZoetisUS.com/poultry.

About Zoetis

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2013, the company generated annual revenues of $4.6 billion. With approximately 9,800 employees worldwide at the beginning of 2014, Zoetis has a local presence in approximately 70 countries, including 27 manufacturing facilities in 10 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries.  For more information, visit www.zoetis.com.

Zoetis is the proud sponsor, with the Smithsonian Institution Traveling Exhibitions, the American Veterinary Medical Association, and the American Veterinary Medical Foundation, of the mobile educational exhibit Animal Connections: Our Journey Together.  Families visiting the exhibit will explore the vast bonds between people and animals and learn about the important role veterinarians play in protecting animal and human health.  For more information, visit https://www.zoetis.com/animal-connections-tour/.

[i] Cracking down on poultry disease with egg yolk. Agriculture Research.  2012 July;60(6):9. U.S. Department of Agriculture, Agricultural Research Service.

[ii] Schering-Plough Animal Health (now Merck Animal Health) introduced Clinacox (diclazuril) to the U.S. in 1999.

Media Contacts:                                          

Devon Brady
Zoetis Inc.
(919) 314-2540

Diana Delmar
PR Works
(301) 963-0630